The content of this page is not yet available in English.
Publications récentes
Labrie F, Cusan L, Gomez JL, Cote I, Berube R, Belanger P, Martel C, Labrie C. Effect of one-week treatment with vaginal estrogen preparations on serum estrogen levels in postmenopausal women. Menopause (New York, N.Y.) , 2009. 16: 30-6
Labrie F, Cusan L, Gomez JL, Cote I, Berube R, Belanger P, Martel C, Labrie C. Effect of intravaginal DHEA on serum DHEA and eleven of its metabolites in postmenopausal women. The Journal of steroid biochemistry and molecular biology, 2008. 111: 178-94
Labrie F, Cusan L, Gomez JL, Martel C, Berube R, Belanger P, Belanger A, Vandenput L, Mellstrom D, Ohlsson C. Comparable amounts of sex steroids are made outside the gonads in men and women: Strong lesson for hormone therapy of prostate and breast cancer. The Journal of steroid biochemistry and molecular biology, 2008. Epub
Labrie F, Cusan L, Gomez JL, Martel C, Berube R, Belanger P, Chaussade V, Deloche C, Leclaire J. Changes in serum DHEA and eleven of its metabolites during 12-month percutaneous administration of DHEA. The Journal of steroid biochemistry and molecular biology, 2008. 110: 1-9
Labrie F, Belanger A, Belanger P, Berube R, Martel C, Cusan L, Gomez J, Candas B, Chaussade V, Castiel I, Deloche C, Leclaire J. Metabolism of DHEA in postmenopausal women following percutaneous administration. The Journal of steroid biochemistry and molecular biology, 2007. 103: 178-88
Labrie F, Belanger A, Labrie C, Candas B, Cusan L, Gomez JL. Bioavailability and metabolism of oral and percutaneous dehydroepiandrosterone in postmenopausal women. The Journal of steroid biochemistry and molecular biology, 2007. 107: 57-69
Labrie F, Bélanger A, Bélanger P, Bérubé R, Martel C, Cusan L, Gomez J, Candas B, Castiel I, Chaussade V, Deloche C, Leclaire J. Androgen glucuronides, instead of testosterone, as the new markers of androgenic activity in women. The Journal of steroid biochemistry and molecular biology, 2006. 99: 182-8
Candas B, Labrie F, Gomez JL, Cusan L, Chevrette E, Lévesque J, Brousseau G. Relationship among initial serum prostate specific antigen, prostate specific antigen progression and prostate cancer detection at repeat screening visits. The Journal of urology, 2006. 175: 510-6; discussion 516-7
Labrie F, Bélanger A, Luu-The V, Labrie C, Simard J, Cusan L, Gomez J, Candas B. Gonadotropin-releasing hormone agonists in the treatment of prostate cancer. Endocrine reviews, 2005. 26: 361-79
Labrie F, Candas B, Cusan L, Gomez JL, Lévesque J, Chevrette E, G Brousseau. Prostate Cancer Screening and Early Treatment: The Only Possibility for a Major Impact on Survival in Prostate Cancer In: Labrie F, Koutsilieris M, eds. Prostate Cancer: Understanding the Pathophysiology and Re-Designing A Therapeutic Approach Athens, Greece: Paschalidis Medical Publications, 2004. p.67-78.